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Effect of modulation of the transferrin receptor on gallium-67 uptake and
cytotoxicity in lymphoma cell lines
AE van Leeuwen-Stokl, GJ Schuurhuis', AM Drfgerl, AWJ Visser-Platierl, GJJ Teule2 and
PC Huijgens1
Departments of'Hematology and 2Nuclear Medicine, Free University Hospital, Amsterdam, The Netherlands.
Summary Gallium-67 is a radionuclide that accumulates in haematological malignancies and is used for
diagnostic purposes. Uptake of 67Ga into the cell occurs via the transferrin receptor, which is differentially
expressed during the various cell cycle phases. With the aim of selectively increasing 67Ga uptake, we studied
whether the transferrin receptor (TfR) expression could be modulated in the U937 and U715 lymphoma cell
lines by cytostatic drugs inducing cell cycle phase accumulation. We tested clinically relevant drugs such as 1-f-
D-arabinofuranosylcytosine (Ara-C), hydroxyurea and methotrexate. Cytotoxicity was determined by testing
the clonogenic capacity ofthe lymphoma cell lines. All three drugs induced an increase in S-phase content, TfR
expression and 67Ga uptake in U937 and U715 single cells. The combinations of drugs and 67Ga resulted in an
additive effect on the clonogenic capacity. In U937 spheroids, cultured by the fibrin clot technique, we found an
accumulation in the S-phase too as well as an increase of the transferrin receptor expression after Ara-C
preincubation. As in single cells 67Ga uptake was increased without synergistic effects on the clonogenic
capacity. In conclusion, priming with drugs induces increased transferrin receptor expression and 67Ga uptake.
Inhibition of clonogenic capacity was additive rather than synergistic.
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Gallium-67 citrate (67Ga) is an established diagnostic tracer
which selectively accumulates in malignancies such as
melanoma, lung cancer and malignant lymphoma (Manfredi
and Weiss, 1978). Based on the particular emission spectrum
of67Ga (photons and low-energy electrons) the possibility has
been considered that this radionuclide might have a
therapeutic potential as well. In previous studies we have
described the uptake and radiotoxicity of 67Ga in haemato-
logical cell lines in vitro (Jonkhoff et al., 1993; Van Leeuwen-
Stok et al., 1993) and in leukaemic blast cells ex vivo
(Jonkhoff et al., 1995a). Furthermore, phase I/II trials with
67Ga in patients with acute leukaemia and lymphoma were
performed and some short-lived responses have been noted
(Huijgens et al., 1993; Jonkhoff et al., 1995b). Like iron, 67Ga
binds to the transport molecule transferrin and enters the
cells via the transferrin receptor (Harris and Sephton, 1977;
Van Leeuwen-Stok et al., 1993). The iron requirements of the
cell and the expression of the transferrin receptor varies
during the cell cycle, being highest during the S- and G2M-
phases (E Pelosi-Testa et al., 1986, unpublished observa-
tions). Previously, while using iron depletion, we have shown
a positive relation between the transferrin receptor expression
and 67Ga uptake in the human lymphoid cell line U715 (Van
Leeuwen-Stok et al., 1993). Therefore, increasing 67Ga uptake
in cells may be affected not only by increasing the 67Ga
concentration in the medium surrounding the cells but, more
selectively, by increasing the transferrin receptor expression.
Various agents are able to increase transferrin receptor
expression, among which are desferrioxamine (Hedley et al.,
1985), phorbol esters (Neckers, 1991) and anti-cancer drugs.
For example, incubation with 1-fl-D-arabinofuranosylcytosine
(Ara-C) induces an increase in the number of transferrin
receptors on oropharyngeal carcinoma KB cells (Caraglia et
al., 1993). Furthermore, hydroxyurea treatment increased
transferrin receptor expression in human T-cell leukaemia
cells CCRF-CEM (Hedley et al., 1985).
In this in vitro study we examined the effects of Ara-C.
hydroxyurea and methotrexate on the expression of the
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transferrin receptor, 67Ga uptake and cytotoxicity in two
lymphoma cell lines (U937 and U715). In this study both
single cells and multicellular spheroids, as a model for
micrometastasis (Van Leeuwen-Stok et al., 1996), were used.
Materials and methods
Cells and culture conditions
U937, a human monoblastic/lymphoid cell line, was obtained
commercially (ATCC, Rockville, MD, USA). U715, a human
B-cell lymphoid cell line, was generously provided by Dr K
Nilsson (University Hospital, Uppsala, Sweden). Cells were
maintained in serum-free medium RPMI-1640-L-glutamine
(Gibco, Breda, The Netherlands) as described earlier (Van
Leeuwen-Stok et al., 1993) containing 25 nM ferrous chloride
(Merck, Darmstadt, Germany) and 25 ,tg ml-' iron-free
purified human transferrin (hTf; Behringwerke, Marburg,
Germany). At the start of all experiments the cells were
>95% viable as determined by the trypan blue exclusion test.
Cell cultures were checked regularly to be negative for
mycoplasma using a Gen Probe Kit (Lab Serv Benelux,
Apeldoorn, The Netherlands).
Multicellular spheroids
Multicellular spheroids were cultured as described earlier (Van
Leeuwen-Stok et al., 1996). In short, 0.2 x 106 cells were
harvested and centrifuged at 2000 g for 2 min after which the
supernatant was discarded. Thecells were resuspended in 7.5 P1
fibrinogen (20 mg ml-'; F 4753, Sigma, St Louis, MO, USA)
and 4 pl thrombin (20 U ml-', Merck) solution and incubated
at 37°C for 10 min during which a fibrin clot was formed. The
cell clots were cultured for 2 days in a spinner flask (Bellco,
Vineland, NJ, USA) in a 5% carbon dioxide incubator at 37°C
with the magnetic stirrer rotating at 100 r.p.m. Spheroids with
a diameter of 2-3 mm were used for experiments. Spheroids
were harvested and plated in 24-well plates which were coated
with 1% agarose in phosphate-buffered saline (PBS) (Agarose
L, Pharmacia, Uppsala, Sweden) to prevent attachment to the
bottom of the wells. After drug and/or 67Ga incubation,
spheroids were dispersed into single cells by incubation for
20 min at 37°C with 20 pl (0.5 U) human plasmin (Chromo-
genix, M6lndal, Sweden) per spheroid.Transferrin receptor modulation and 67-Ga cytotoxicity
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67Ga citrate
67Gallium was obtained commerically (Mallinckrodt Diag-
nostics Holland, Petten, The Netherlands) as 67Ga chloride.
67Ga citrate with a low concentration of citrate was prepared
as described previously (Van Leeuwen-Stok et al., 1993). The
specific activity of the resulting 67Ga citrate solution was
about 40 pCi pmol-l 67Ga. The 67Ga concentration used in
the experiments was 80 pCi ml-'.
Cytostatic drugs
l-f3-D-arabinofuranosylcytosine (Ara-C, 20 mg ml-') was
obtained from Multipharma (Weesp, The Netherlands),
hydoxyurea (20 mg ml-') from Sigma (St Louis, USA) and
methotrexate (25 mg ml-1) from Pharmachemie (Haarlem,
The Netherlands).
Preincubation with drugs
U937 and U715 single cells were preincubated in 25 cm3
culture flasks for 3, 4, 5 and 6 days with various
concentrations of the drugs in order to find the optimal
preincubation for TfR expression. Drug concentrations are
desired which cause an increase ofTfR expression but do not
extensively inhibit cell proliferation. Fifty per cent inhibition
was chosen as the arbitrary maximal inhibiting effect of a
single agent so that the sum of the individual effects of drug
and 67Ga could not exceed 100%. The initial cell
concentration was 0.2 x 106 cells ml-' for U937 cells and
0.1 X 106 cells ml-1 for U715 cells. After preincubation the
cells were harvested, analysed for TfR expression and DNA
distribution and used for 67Ga uptake and cytotoxicity
studies. Multicellular spheroids were preincubated with or
without drugs in 24-well plates. After preincubation one part
of the spheroids for each of the treatments was dispersed to
single cells with plasmin for DNA and TfR analysis. The
other part of the spheroids for each of the treatments was
washed and plated in fresh medium with or without
80 pCi ml-' 67Ga for 24 h. After this incubation all
spheroids were dispersed into single cells for plating in the
clonogenic assay.
Flow cytometric DNA analysis
Nuclei were prepared for flow cytometric DNA analysis with
propidium iodide (PI) according to the method of Vindel0v
and Christensen (1994). Nuclei (20 000 events) were analysed
using the FACScan (Becton Dickinson, Mountain View,
CA). Cell cycle analysis was performed using CellFit DNA
analysis software (Becton Dickinson).
Flow cytometric transferrin receptor analysis
Transferrin receptor expression was measured using flow
cytometry. The anti-TfR monoclonal antibody (MAb; CD71)
used was an IgGI fluorescein isothiocyanate (FITC)-
conjugated mouse anti-human MAb. FITC-conjugated
mouse IgGI MAb against F(ab) was used as negative
control (Dako, Glostrup, Denmark). Cells were suspended
in PBS with 0.1% bovine serum albumin (BSA) in a
concentration of 4 x 106 cells ml-'. The MAbs were diluted
20 times with PBS-BSA. Cell suspension (50 Ml) was
incubated with 50 pl MAb for 30 min on ice. Cells were
washed twice with PBS-BSA and finally suspended in 500 Ml
PBS-BSA. Fluorescence intensity was analysed with the
FACScan. Data are expressed as the fluorescence index (FI;
arbitrary units) which was calculated as follows:
FI MFI sample - MFI negative control
MFI negative control
where MFI is the mean fluorescence intensity.
Cellular uptake of67Ga
After the 24 h incubation period spheroids and single cells
were transferred to tubes on ice, washed twice with ice-cold
PBS and counted in a gamma counter (1470 Wizard, Wallac,
Turku, Finland). Hereafter, these spheroids were dispersed,
the cells were washed once and counted to distinguish
between 67Ga uptake in the entire spheroid and 67Ga uptake
in the spheroid cells alone. 67Ga uptake was expressed as
follows:
Counts per cell = c.p.m. pellet - c.p.m. background
cell number
where c.p.m. is counts per minute, corrected for the half-life
of 67Ga.
Clonogenic cell survival
Cells were washed once with PBS and 0.3 x 104 cells were
resuspended in placenta-conditioned Iscove's modified
Dulbecco's medium with fetal bovine serum (13%; Gibco),
methylcellulose (1%; Fluka Biochemika, Buchs, Germany),
glutathione-reductase (100 pg ml- ; Boehringer, Mannheim,
Germany), BSA (1%) and human transferrin (0.6 pg ml-';
Behringwerke, Marburg, Germany) according to Schlunk and
Schleyer (1980). Cells were plated in 24-well plates (200 pl per
well) and after 7 days of incubation colonies (>40 cells) and
clusters (8-40 cells) were counted.
Statistics
All data are presented as the mean of n experiments (n is
indicated in Table I). Bars indicate the standard error of the
mean. In Figures 1-4, an independent Student's t test
(cx =0.05) has been used. The hypothesis tested was: the
difference in means=0 (no statistically significant difference).
Results
Preincubation with cytostatic drugs
For most concentrations of drugs tested, 5 days of
preincubation was optimal for up-regulation of the TfR.
The concentrations found to inhibit cell proliferation by 50%
at maximum are shown in Table I. It should be noted that
these concentrations do not necessarily cause a maximal
increase of the TfR expression. For further experiments drug
concentrations marked with an asterisk in Table I were used,
unless otherwise indicated.
Cell cycle effect of drug preincubation
In Figure 1 the effect of 5 days' preincubation on cell cycle
distribution in the two cell lines is shown. Preincubation with
Ara-C, hydroxyurea and methotrexate induced increases in S-
phase cells in both U937 and U715 cells, which represent
statistically significant differences from control experiments
for all drugs used except for the combination U715 and
methotrexate (Figure 1). Furthermore, in U937 cells a
tendency towards an increase in the percentage of G2M-
phase cells was seen, which was significant for hydroxyurea.
Transferrin receptor expression and 67Ga uptake
All drugs caused an increase of the TfR expression (FI) after
5 days of preincubation in both cell lines, although a
statistically significant difference was not reached in all cases
(Figure 2a and b). These increased TfR expressions were in
qualitative concordance with the 67Ga uptake shown in the
right columns of Figure 2. Here also a statistically significant
difference was not reached for all cases. Although increases of
the TfR expression and 67Ga uptake parallel each other, there
are discrepancies between the extent of both. This is probablyTransferrin receptor modulation and 67-Ga cytotoxicity
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Table I Effect of 5 days' preincubation with cytostatic drugs on the proliferation of U937 and U715
single cells and U937 spheroids
Drug concentration Proliferation
(ItgmRl-) n (%
U937 single cells
Control 8 0.82+0.lOa (100)b
Ara-C 0.007c 8 0.54+0.15 (66)
HU 5C 5 0.45+0.21 (55)
MTX 0.009c 5 0.41+0.09 (50)
U715 single cells
Control 6 0.53+0.14 (100)
Ara-C 0.0025c 6 0.28+0.10 (53)
Ara-C 0.005 3 0.23 +0.06 (43)
Ara-C 0.01 3 0.08+0.08 (15)
HU 4C 3 0.30+0.09 (57)
MTX 0.0075c 6 0.26+0.23 (49)
U937 spheroids
Control 4 0.99+0.21 (100)
Ara-C 0.0035c 4 0.68+0.07 (69)
Proliferation, number ofviable cells at the end of the incubation time minus number of viable cells
seeded. Initial cell concentration was 0.2 x 106 cellsml-' for U937, 0.1 x 106 cells ml- for U715 cells and
0.2 x 106 U937cells perspheroid. aMean+s.d. x 106cellsml-'. bPercentageproliferationcompared with
control cells. cIndicates drug concentation used for furtherexperiments. n, number ofexperiments; Ara-
C, 1-fJ-D arabinofuranosyl-cytosine; HU, hydroxyurea; MTX, methotrexate.
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Figure 1 Cell cycle phase distribution of single cells after
preincubation with cytostatic drugs. Two cell lines U937 (a) and
U715 (b) were preincubated with or without drugs for 5 days and
thereafter assayed for cell cycle accumulation as described in
Materials and methods. Values are mean+s.d. (n = 3 8, see
Table I). *Indicates a statistically significant increase (P<0.05).
Control ME; Ara-C M; hydroxyurea and methotrexate
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due to the relatively small increase of TfR expression and
67Ga uptake which may become clear from Figure 3. Figure 3
shows that further increase of the Ara-C concentrations in
U715 cells up to cytotoxicity levels that exceeded 50%
proliferation inhibition (0.005 and 0.01 jg ml-') led to a
further increase of transferrin receptor expression, which
resulted in a relatively large increase of 67Ga uptake in these
cells. Thus, there is a good parallel between increase of TfR
expression and 67Ga uptake but these are relatively small at
the drug concentrations that can be used without causing
extreme proliferation inhibition.
Clonogenic capacity
Figure 4 shows the clonogenic capacity after 67Ga treatment
in cells preincubated with or without drugs. The open bars
indicate the expected clonogenic capacity (Exp), which
represents the sum of the individual effects of 67Ga and
drug. This figure shows that 67Ga incubation after Ara-C
preincubation in both cell lines resulted in a higher decrease
of the clonogenic capacity than expected (open bars in the
second columns). However, the clonogenic capacity than
expected (open bars in the second columns). However, the
clonogenic capacity after 67Ga incubation both with or
without Ara-C preincubation is equal (compare hatched
bars in first and second columns). This may be caused by
stimulation of the clonogenic capacity of the residual cells by
Ara-C alone, although this stimulation is not statistically
significant from the control cells. Since this stimulation by
Ara-C itself makes the results difficult to interpret, we also
used a higher concentration of Ara-C despite the pronounced
proliferation inhibition. In U715 cells 0.01 Mg ml-' Ara-C led
to an inhibition of the clonogenic capacity of 50%. When
67Ga and Ara-C were used together an 86% inhibition was
found (data not shown). The expected value of the
combination would be 95% inhibition (50% for Ara-C and
45% for 67Ga) showing not more than an additive effect. 67Ga
incubation after hydroxyurea and methotrexate preincubation
resulted in a lower or equal clonogenic capacity compared
with the expected values (third and fourth columns of Figure
4).
Effect of Ara-C preincubation in multicellular spheroids
In order to see whether drug preincubation can be of benefit
for 67Ga treatment in a micrometastasis model, we used
multicellular spheroids (Van Leeuwen-Stok et al., 1996).
Since in the single cell experiments similar effects were found
with the three drugs in both cell lines, we have chosen to use
one particular combination, Ara-C in U937 spheroids. In
Table I the Ara-C concentration used and the effect of
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preincubation on the proliferation is summarised. Figure 5a
shows the effect of preincubation with Ara-C on the cell cycle
distribution. As in U937 single cells, Ara-C induced
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accumulation in the S- and G2M-phase. The TfR expression
could be up-regulated by a factor of 2 (Figure 5b, left
columns), but this did not result in a similar pronounced
increase of the 67Ga uptake, which is shown in the right
columns of Figure 5b. 67Ga incubation in multicellular
spheroids for 1 day resulted in 35% inhibition of the
clonogenic capacity in U937 spheroid-derived cells (Figure
5c). Ara-C preincubation did not result in a higher inhibition
of the clonogenic capacity of the remaining cells than could
be expected from the individual effects of 67Ga and Ara-C in
spheroid-derived cells (Figure 5c).
Discussion
In former studies we have shown a direct relation between
transferrin receptor expression after iron depletion and 67Ga
uptake (Van Leeuwen-Stok et al., 1993). Therefore, one way
to increase 67Ga uptake might be to increase transferrin
receptor expression. There are various ways to increase the
transferrin receptor expression on cultured cells such as iron
chelation by desferrioxamine (Akin and Sonnenfeld, 1993) or
the use of phytohaemagglutinin and phorbol esters (Neckers,
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Figure 2 Transferrin receptor expression and 67Ga uptake in
single cells after cytostatic drug preincubation. U937 (a) and
U715 (b) cells were preincubated with or without drugs for 5
days. After this, TfR expression and 67Ga uptake (24h) were
measured. Values represent mean percentage of control+s.d.
(n =3-8, see Table I). Control values without drug= 100%.
*Indicates a statistical significance compared with the control
values (P<0.05). Control MI; Ara-C M; hydroxyurea and
methotrexate M.
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Figure 3 Correlation between TfR expression and 67Ga uptake
in U715 single cells after Ara-C preincubation. U715 cells were
preincubated for 5 days without or with 0.0025, 0.005 and
0.01I Mgml-
1 Ara-C as described in Materials and methods. TfR
expression and 67Ga uptake were measured. The values
(mean+s.d., n=3-6) are expressed as percentage compared
with the control values without Ara-C. There is a positive
logarithmic correlation (r =0.98).
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Figure 4 Clonogenic capacity after 67Ga incubation and
preincubation with or without cytostatic drugs in single cells.
U937 (a) and U715 (b) single cells were incubated with 7Ga for
24h after a preincubation period of 5 days. The values are
expressed as mean percentage of control+s.d. (no drugs, no
67Ga= 100%, n =3-8). For U937 cells, mean control = 133 CFU
per 3000 cells, and for U715 cells, mean control= 199 CFU per
3000 cells. , without 67Ga (-) and without cytostatic drug
(first columns) or with arabinosidecytosine (Ara-C, second
columns), hydroxyurea (HU, third columns) or methotrexate
(MTX, fourth columns). M, with 67Ga (+) and without or with
cytostatic drug (see above). Exp, the expected value, based on the
individual effects of cytostatic drug and 67Ga.
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Figure 5 Cell cycle phase distribution, transferrin receptor
expression, 67Ga uptake and clonogenic capacity in U937
spheroid cells after 5 days Ara-C preincubation. U937 svheroids
were preincubated without (E) or with 0.0035 pgml- Ara-C
( ). The values are expressed as mean percentage of
control+s.d. (n=4, control values without drug= 100%).
Indicates a statistically significant increase (P<0.05). (a) Cell
cycle distribution (measured as described in Materials and
methods). (b) TfR expression and 67Ga uptake (measured as
described in Materials and methods). (c) Clonogenic capacity
(measured as described in Materials and methods). For spheroid
cells mean control= 139 CFU per 3000 cells Exp, the expected
value, based on the individual effects of Ara-C and 67Ga.
1991). However, these treatments do not seem very feasible
for in vivo therapy. Cytostatic drugs commonly used for
haematological malignancies, like Ara-C (Caraglia et al.,
1993) and hydroxyurea (Hedley et al., 1985), are also able to
induce increases of transferrin receptor expression and were
therefore thought to be likely candidates to test in
combination with 67Ga.
In this study we have shown that Ara-C, hydroxyurea
and methotrexate induced an accumulation in the S-phase
of the cell cycle in U937 and U715 cells. Since the iron-
requiring DNA synthesis takes place in the S-phase of the
cell cycle it might be expected that the transferrin receptor
expression increases when cells are accumulating in the S-
phase. Indeed, the transferrin receptor expression was up-
regulated by 5 days' preincubation with Ara-C, hydroxyurea
and methotrexate and these increases are more pronounced
than those found previously after 1 day of incubation
(unpublished observations). However, the increases were less
than expected. For hydroxyurea this may be explained by
its mechanism of action. Hydroxyurea inhibits the activity
of the M2 subunit of the enzyme ribonucleotide reductase
(Chitambar et al., 1988). Since the iron requirements of the
cell appear to be directly related to increased activity of the
M2 subunit of ribonucleotide reductase (Eriksson et al.,
1984), inhibition of the M2 subunit by hydroxyurea may
decrease the iron requirements. Since also the transferrin
receptor expression is related to the iron requirements
(Pelosi-Testa et al., 1986), the transferrin receptor expression
and consequently the 67Ga uptake might be less up-
regulated than might be expected from the increased S-
phase accumulation. For Ara-C no apparent explanation is
available. The effect of the drug methotrexate was studied,
since in a previous study we have found that after
preincubation an antagonist effect on proliferation to 67Ga
occurred, which hypothetically might be due to a decreased
transferrin receptor expression (unpublished results). How-
ever, in this study, while using about the same methotrexate
concentrations, we found an increase of transferrin receptor
expression and 67Ga uptake after preincubation. This did
not result in synergistic effects on the clonogenic capacity of
remaining cells. Therefore, decreased transferrin receptor
expression was not the cause of the antagonistic effect seen
on proliferation (unpublished results) and clonogenic
capacity (this study). In addition, relatively flat dose-
response curves might contribute to the disappointing effects
on the clonogenic capacity, e.g. increasing the uptake of
67Ga three times by a higher external 67Ga concentration
resulted in an increase of toxicity of only 20% (unpublished
results).
Although in this study the increases in TfR expression
were associated with higher 67Ga uptake, there are
discrepancies between the extent of both increases. This is
probably partly a result of the relatively low increases of the
TfR expression. The presence ofinsulin in our culture system,
a growth factor essential for cell proliferation, could have
induced up-regulation of the transferrin receptor (Akin and
Sonnenfeld, 1993). Therefore, the control cells in our culture
system may already be primed for transferrin receptor
expression resulting in a less pronounced effect of the
cytostatic drugs. Nevertheless, when using a series of Ara-C
concentrations a dose-dependent increase of TfR expression
and 67Ga uptake could be demonstrated clearly suggesting the
potency of this approach.
To investigate whether the treatment schedules used can be
of benefit in micrometastasis we used multicellular tumour
spheroids. The transferrin receptor expression could be up-
regulated by a factor of 2 by Ara-C in multicellular
spheroids. However, this increases the 67Ga uptake by a
factor of 1.4 with only a minor effect on the clonogenic
capacity. This might be related to the barrier for 67Ga
penetration present in the spheroid (Van Leeuwen-Stok et al.,
1996) as well as to the flat dose-response curves.
Higher drug concentrations may lead to higher TfR
expression and 67Ga uptake which may induce a significant
inhibition of the clonogenic capacity. In this study we have
chosen drug concentrations which induce suboptimal
proliferation inhibition and cell death to prevent too much
selection in the cell population by preincubation with the
drug. Steel (1994) proposed that the benefits of priming with
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suboptimal doses including cell cycle phase accumulation are
doubtful when cells can be killed directly with higher doses.
We have shown that the use of a combined treatment with
low doses of different agents results in a cytotoxic effect on
the tumour that is in most cases higher or equal to the sum of
individual toxicities. If these results can be extrapolated to
the in vivo situation, it will therefore depend on the relative
side-effects of both modalities in the patient whether
combination treatment is of clinical advantage.
We may conclude that it is possible to induce increase of
transferrin receptor expression and 67Ga uptake by Ara-C,
hydroxyurea and methotrexate which results in an additive
effect on the clonogenic capacity in lymphoma cells in vitro
when combined with 67Ga. Such a combination treatment
may be of benefit for treatment of malignant lymphoma
depending on the relative side-effects.
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